Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01690663 · ClinicalTrials.gov registry record · NA

Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25%

A NA study of Post-surgical Pain, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
89
Enrollment target
1
Study location

NCT01690663: Completed NA study of Post-surgical Pain, sponsored by University of Pennsylvania.

NCT01690663 is a NA study of Post-surgical Pain that has completed, run by University of Pennsylvania. The registered enrollment target is 89 participants, below the 196-participant average among 7 other Post-surgical Pain trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01690663, a NA study of Post-surgical Pain, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
89 participants
Enrollment target
1
Study location

Study Summary

When used in conjunction with a local anesthetic, dexamethasone may prolong both the sensory and motor effects of high supraclavicular brachial plexus nerve block (SBP) in arthroscopic shoulder surgery. This study seeks to determine if there is a relationship between the duration of sensory and motor blockade in supraclavicular brachial plexus nerve blocks (SBP) when combined with increasing doses of dexamethasone.

Primary Outcome

This is defined as time from the completion of the block to the initiation of supplemental analgesia medications after hospital discharge. The patients were evaluated on different days to capture the exact end time, which was the initiation of supplemental analgesia medication. We intentionally contacted patients several times to capture the time as early as possible to minimize recall bias.

Conditions Studied

Interventions

  • DRUG Dexamethasone
  • DRUG normal saline
  • DRUG Bupivacaine 0.25%

Study Locations (1)

Pennsylvania

  • Penn Presbyterian Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2012-09
Est. Completion 2015-02
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT01690663 record still lists

NCT01690663 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 196-participant average among 7 other Post-surgical Pain trials with a reported enrollment target (55% lower).

The record links to 1 condition, with Post-surgical Pain appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.

NCT01690663 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01690663 about?

NCT01690663 is a clinical study titled "Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25%". When used in conjunction with a local anesthetic, dexamethasone may prolong both the sensory and motor effects of high supraclavicular brachial plexus nerve block (SBP) in arthroscopic shoulder surgery. This study seeks to determine if there is a relationship between the duration of sensory and moto...

What is the current status of trial NCT01690663?

This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2012-09. Estimated completion is 2015-02.

What conditions does trial NCT01690663 study?

This clinical trial studies the following conditions: Post-surgical Pain.

What interventions are being tested in trial NCT01690663?

The interventions under investigation include: Dexamethasone (DRUG), normal saline (DRUG), Bupivacaine 0.25% (DRUG).

Who is sponsoring clinical trial NCT01690663?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01690663 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-surgical Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01690663, the US trial registry maintained by the National Library of Medicine. NCT01690663 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.